What is the difference between Melanotan I and Melanotan II 10mg?
Melanotan I (MT1, generic name alfamelanotide) and Melanotan II (MT2) are both synthetic melanocortin receptor agonist peptides. Their core function is to promote melanin synthesis and enhance skin tanning efficiency. Both are available in mainstream 10mg bottles of research-grade powder. Although they share the same core target, their receptor selectivity, efficacy, usage regimen, side effects, regulatory compliance, and market cost differ significantly. The following is a detailed industry comparison under the 10mg specification, with data derived from peptide research industry testing and overseas pharmaceutical registration documents.
I. Differences in Basic Molecular Structure and Receptor Targeting
This dimension is the core source of all differences between the two, directly determining their efficacy range and safety characteristics. The molecular purity and dosage form are basically the same in the 10mg specification; the difference lies in their targeting.
- Melanotan I (10mg): A linear peptide with extremely high receptor selectivity, precisely targeting only the human MC1R melanocortin receptor. Targeting only skin melanocytes, with no additional systemic receptor activation, its molecular mechanism is pure and specifically targets pigmentation regulation.
- Melanotan II (10mg): Belongs to a cyclic heptapeptide structure, with non-selective receptors, simultaneously activating multiple receptors including MC1R, MC3R, MC4R, and MC5R. In addition to targeting skin melanin, it also acts on receptors related to metabolism, reproduction, and the nervous system, providing diverse systemic effects.
II. Differences in Practical Usage of the 10mg Formulation
Due to differences in molecular activity, the dosage, frequency, and cycle of the 10mg powder after reconstitution are completely different for both, representing the industry's standard practice.
- Melanotan I (10mg): Mild in activity and metabolically stable, requiring no high-frequency injections during the loading phase. The overall loading cycle is 4-6 weeks, requiring only 2 injections per week, with a standard single dose of 0.5-1mg. 10mg powder can completely cover one full cycle of tanning and shaping. During the maintenance phase, a low-dose injection once a week is sufficient to stabilize skin tone, resulting in lower overall usage frequency and simpler operation.
- Melanotan II (10mg): Stronger molecular activity, faster onset of action, but shorter metabolic cycle. Loading cycle is 2-4 weeks, requiring daily injections of 0.25-0.5mg per dose. A single loading cycle requires 14-21 injections. 10mg powder is sufficient for complete saturated coloring. Maintenance period is the same as MT1, requiring 2-3 injections per week, but the overall initial frequency of administration is significantly higher than MT1.
III. Differences in Core Efficacy Focus
At the same 10mg dose, the two products differ in efficiency and texture regarding their core tanning efficacy. MT2 also possesses additional benefits not found in MT1, a key factor in industry application selection.
- Melanotan I (10mg): Highly specific efficacy, focusing solely on safe skin tanning and even pigment deposition. The tanning effect is natural and translucent, with high skin evenness, avoiding localized dark spots or uneven pigmentation. It has no fat reduction, endocrine regulation, or sexual function-related effects, making it suitable for users seeking only natural tanning without other concerns.
- Melanotan II (10mg): Offers higher basic tanning efficiency than MT1, with faster melanin deposition and deeper color, achieving noticeable tanning results in a short period. It also boasts three additional benefits: appetite suppression and fat reduction; regulation of reproductive system function and increased libido; and improved metabolic state. The market-derived drug Bremlanotide (used for the treatment of female sexual dysfunction) is based on the MT2 molecular structure.
IV. Differences in Side Effects and Safety
Combined with the standard 10mg dosage, the side effect risks and discomfort symptoms differ significantly between the two. MT1 is significantly safer than MT2, which is the core reason for prioritizing MT1 in the medical field.
- Melanotan I (10mg): Very few and mild side effects. Only a very small number of people experience transient mild nausea and slight skin redness upon first use; there are no persistent adverse reactions. No reproductive or metabolic system-related side effects. Long-term, standardized use is well-tolerated, and there are no recorded cases of severe adverse reactions.
- Melanotan II (10mg): More numerous and more frequent side effects. Common short-term reactions: nausea, dizziness, facial flushing, and drowsiness after injection; specificity.
Shaanxi Lv Ke Chun Yuan Biotechnology Co., Ltd
Our address
Huaxia Yue World, Weibin District, Baoji City, Shaanxi Province
Phone Number
+86-13571783771
